4551 — Torii Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Torii Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	42,998	41,700	46,987	48,896	54,638
Cost of Revenue
Gross Profit	22,296	21,738	24,338	23,380	24,791
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,560	37,708	42,371	43,358	49,640
Operating Profit	37,438	3,992	4,616	5,538	4,998
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	37,700	4,225	4,767	5,722	5,593
Provision for Income Taxes
Net Income After Taxes	27,367	3,496	3,375	3,944	4,120
Net Income Before Extraordinary Items
Net Income	27,367	3,496	3,375	3,944	4,120
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27,367	3,495	3,374	3,944	4,119
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	43.8	146	121	140	148
Dividends per Share